Viking® ( (NYSE: VIK) today announced the Explorers’ Sale, providing North American travelers with new booking incentives ...

Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $38.88 which represents a decrease of $-0.43 or -1.09% from the prior close of $39.31. The stock opened at $38.25 and touched a ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the ...

Numerous Norse heritage preservation organizations have built authentic replicas of Viking ships. Embarking on a journey aboard these vessels offers a unique glimpse into the advanced maritime ...

JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.

Viking Therapeutics (VKTX) has received a new Buy rating, initiated by Stifel Nicolaus analyst, Annabel Samimy.Stay Ahead of the ...

Chicago, IL – January 2, 2024 – Zacks.com announces the list of stocks and featured in the Analyst Blog. Every day the Zacks ...

Viking has announced the launch of its Explorers' Sale, providing North American travelers with new booking incentives across ...

Viking Therapeutics only has a current market cap of $4.3 billion, with an EV in the range of $3.4 billion. The biotech has a cash balance of $930 million to provide the funding for the big GLP-1 ...

providing North American travelers with new booking incentives across the company’s extensive range of river, ocean and expedition voyages. From now through January 31, 2025, Viking is offering ...

Jorvik Viking Festival, is set to celebrate its 40th year in York from February 17 to 23 with a wide range of activities designed to ...